Drugs Made In America Acquisition (DMIIU) Common Equity (2024 - 2026)
Drugs Made In America Acquisition (DMIIU) recorded Common Equity of -$17.93 million in Q2 2026.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIU) Common Equity (2024 - 2026) Analysis & Trends
At the end of FY2025, Drugs Made In America Acquisition reported Common Equity of -$17.77 million.
- Across earlier years, Common Equity came in at -$116,719 in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.93 Mn |
| Dec 31, 2025 | -17.77 Mn |
| Sep 30, 2025 | -17.28 Mn |
| Jun 30, 2025 | -214,119.00 |
| Dec 31, 2024 | -116,719.00 |
API Access
Drugs Made In America Acquisition Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DMIIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();